07:00 , Sep 5, 2016 |  BC Week In Review  |  Clinical News

Omeros preclinical data

In an animal model of arthritis, OMS906 significantly reduced the incidence and severity of arthritis by 86% and 90%, respectively, vs. an undisclosed control (p<0.005 and p<0.01, respectively). OMS906 is an antibody targeting mannan binding...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Clinical News

Omeros preclinical data

In an animal model of PNH, 80% destruction of PNH-like red blood cells was delayed for about 8 days in animals treated with OMS906 vs. <1 day for animals treated with an undisclosed complement 5...